Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus.

MLA

Specchia, Maria Lucia, et al. “Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus.” BioMed Research International, vol. 2014, 2014, p. 704207. EBSCOhost, https://doi.org/10.1155/2014/704207.

APA

Specchia, M. L., de Waure, C., Gualano, M. R., Doria, A., Turchetti, G., Pippo, L., Di Nardo, F., Capizzi, S., Cadeddu, C., Kheiraoui, F., Iaccarino, L., Pierotti, F., Palla, I., Veneziano, M. A., Gliubizzi, D., Sferrazza, A., Nicolotti, N., Porcasi, R., La Torre, G., … Ricciardi, W. (2014). Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus. BioMed Research International, 2014, 704207. https://doi.org/10.1155/2014/704207

Chicago

Specchia, Maria Lucia, Chiara de Waure, Maria Rosaria Gualano, Andrea Doria, Giuseppe Turchetti, Lara Pippo, Francesco Di Nardo, et al. 2014. “Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus.” BioMed Research International 2014: 704207. doi:10.1155/2014/704207.